Illumina Body Map 2: averaged replicates
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MESP1
|
ENSG00000166823.5 | mesoderm posterior bHLH transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MESP1 | hg19_v2_chr15_-_90294523_90294541 | -0.08 | 6.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_106805716 | 4.24 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
chr14_-_106781017 | 3.46 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr14_-_107179265 | 3.28 |
ENST00000390634.2
|
IGHV2-70
|
immunoglobulin heavy variable 2-70 |
chr7_-_150675372 | 3.24 |
ENST00000262186.5
|
KCNH2
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
chr5_-_138725594 | 3.12 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chrX_-_152939252 | 3.10 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr5_-_138725560 | 2.99 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr2_-_89161064 | 2.94 |
ENST00000390241.2
|
IGKJ2
|
immunoglobulin kappa joining 2 |
chr14_-_106539557 | 2.93 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr14_-_106642049 | 2.88 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr14_-_107170409 | 2.80 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr2_+_90198535 | 2.80 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr22_+_23222886 | 2.78 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr11_+_60223312 | 2.75 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr2_-_89161432 | 2.75 |
ENST00000390242.2
|
IGKJ1
|
immunoglobulin kappa joining 1 |
chr14_-_106478603 | 2.72 |
ENST00000390596.2
|
IGHV4-4
|
immunoglobulin heavy variable 4-4 |
chr19_-_47137942 | 2.61 |
ENST00000300873.4
|
GNG8
|
guanine nucleotide binding protein (G protein), gamma 8 |
chr15_-_20170354 | 2.48 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
chrX_-_152939133 | 2.46 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr14_-_106725723 | 2.45 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
chr11_+_60223225 | 2.45 |
ENST00000524807.1
ENST00000345732.4 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr14_-_107219365 | 2.40 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr19_+_42381173 | 2.37 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr14_-_106758101 | 2.35 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
chr19_+_42381337 | 2.34 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr15_-_22473353 | 2.17 |
ENST00000557788.2
|
IGHV4OR15-8
|
immunoglobulin heavy variable 4/OR15-8 (non-functional) |
chr16_+_32077386 | 2.15 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr3_-_49459878 | 2.13 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
chr21_+_10862622 | 2.12 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr14_-_106552755 | 1.97 |
ENST00000390600.2
|
IGHV3-9
|
immunoglobulin heavy variable 3-9 |
chr22_+_23010756 | 1.96 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr14_-_106878083 | 1.95 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr22_+_22749343 | 1.91 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr2_-_175870085 | 1.90 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
chr16_+_23847339 | 1.89 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr11_-_64511789 | 1.86 |
ENST00000419843.1
ENST00000394430.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr22_+_22730353 | 1.85 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr14_-_107083690 | 1.81 |
ENST00000455737.1
ENST00000390629.2 |
IGHV4-59
|
immunoglobulin heavy variable 4-59 |
chr11_-_111320706 | 1.81 |
ENST00000531398.1
|
POU2AF1
|
POU class 2 associating factor 1 |
chr3_-_49459865 | 1.79 |
ENST00000427987.1
|
AMT
|
aminomethyltransferase |
chr2_-_89619904 | 1.77 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr12_+_41086297 | 1.74 |
ENST00000551295.2
|
CNTN1
|
contactin 1 |
chr2_+_90259593 | 1.73 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr2_+_90248739 | 1.72 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr17_-_72968809 | 1.67 |
ENST00000530857.1
ENST00000425042.2 |
HID1
|
HID1 domain containing |
chr14_-_106994333 | 1.67 |
ENST00000390624.2
|
IGHV3-48
|
immunoglobulin heavy variable 3-48 |
chr19_+_54926621 | 1.67 |
ENST00000376530.3
ENST00000445095.1 ENST00000391739.3 ENST00000376531.3 |
TTYH1
|
tweety family member 1 |
chr16_-_776431 | 1.66 |
ENST00000293889.6
|
CCDC78
|
coiled-coil domain containing 78 |
chr6_+_138483058 | 1.64 |
ENST00000251691.4
|
KIAA1244
|
KIAA1244 |
chr7_+_2687173 | 1.63 |
ENST00000403167.1
|
TTYH3
|
tweety family member 3 |
chr1_-_207096529 | 1.58 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr2_+_14772810 | 1.58 |
ENST00000295092.2
ENST00000331243.4 |
FAM84A
|
family with sequence similarity 84, member A |
chr3_-_112356944 | 1.57 |
ENST00000461431.1
|
CCDC80
|
coiled-coil domain containing 80 |
chr8_-_30890710 | 1.56 |
ENST00000523392.1
|
PURG
|
purine-rich element binding protein G |
chr9_+_136399929 | 1.53 |
ENST00000393060.1
|
ADAMTSL2
|
ADAMTS-like 2 |
chr7_-_120497178 | 1.52 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
chr9_-_80263220 | 1.51 |
ENST00000341700.6
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14 |
chr2_+_90458201 | 1.51 |
ENST00000603238.1
|
CH17-132F21.1
|
Uncharacterized protein |
chr14_-_106830057 | 1.51 |
ENST00000390616.2
|
IGHV4-34
|
immunoglobulin heavy variable 4-34 |
chr4_-_185303418 | 1.50 |
ENST00000610223.1
ENST00000608785.1 |
RP11-290F5.1
|
RP11-290F5.1 |
chr3_-_158450475 | 1.48 |
ENST00000237696.5
|
RARRES1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr9_-_139940608 | 1.48 |
ENST00000371601.4
|
NPDC1
|
neural proliferation, differentiation and control, 1 |
chr14_-_91884150 | 1.45 |
ENST00000553403.1
|
CCDC88C
|
coiled-coil domain containing 88C |
chr2_+_219745020 | 1.44 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr7_+_12726623 | 1.44 |
ENST00000439721.1
|
ARL4A
|
ADP-ribosylation factor-like 4A |
chr17_-_78450398 | 1.44 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
chr14_-_106573756 | 1.44 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
chr19_+_17638059 | 1.43 |
ENST00000599164.1
ENST00000449408.2 ENST00000600871.1 ENST00000599124.1 |
FAM129C
|
family with sequence similarity 129, member C |
chr4_-_141348789 | 1.42 |
ENST00000414773.1
|
CLGN
|
calmegin |
chr15_+_75639951 | 1.40 |
ENST00000564784.1
ENST00000569035.1 |
NEIL1
|
nei endonuclease VIII-like 1 (E. coli) |
chr22_+_22516550 | 1.38 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
chr7_-_2883928 | 1.37 |
ENST00000275364.3
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12 |
chrX_+_129305623 | 1.34 |
ENST00000257017.4
|
RAB33A
|
RAB33A, member RAS oncogene family |
chr2_-_133427767 | 1.33 |
ENST00000397463.2
|
LYPD1
|
LY6/PLAUR domain containing 1 |
chr20_+_42574317 | 1.32 |
ENST00000358131.5
|
TOX2
|
TOX high mobility group box family member 2 |
chr5_+_68788594 | 1.30 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
chr1_+_226411319 | 1.30 |
ENST00000542034.1
ENST00000366810.5 |
MIXL1
|
Mix paired-like homeobox |
chr1_-_95392635 | 1.28 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
chr4_-_141348763 | 1.27 |
ENST00000509477.1
|
CLGN
|
calmegin |
chr6_-_31550192 | 1.27 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr15_-_44487408 | 1.26 |
ENST00000402883.1
ENST00000417257.1 |
FRMD5
|
FERM domain containing 5 |
chr13_+_31480328 | 1.26 |
ENST00000380482.4
|
MEDAG
|
mesenteric estrogen-dependent adipogenesis |
chr19_+_17638041 | 1.25 |
ENST00000601861.1
|
FAM129C
|
family with sequence similarity 129, member C |
chr19_+_54926601 | 1.25 |
ENST00000301194.4
|
TTYH1
|
tweety family member 1 |
chr10_+_18689637 | 1.24 |
ENST00000377315.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr16_+_58537737 | 1.23 |
ENST00000561738.1
|
NDRG4
|
NDRG family member 4 |
chr19_-_46476791 | 1.23 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
chr2_+_114163945 | 1.23 |
ENST00000453673.3
|
IGKV1OR2-108
|
immunoglobulin kappa variable 1/OR2-108 (non-functional) |
chr9_-_35650900 | 1.22 |
ENST00000259608.3
|
SIT1
|
signaling threshold regulating transmembrane adaptor 1 |
chr2_+_173600514 | 1.21 |
ENST00000264111.6
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr14_-_107199464 | 1.19 |
ENST00000433072.2
|
IGHV3-72
|
immunoglobulin heavy variable 3-72 |
chr11_+_827553 | 1.19 |
ENST00000528542.2
ENST00000450448.1 |
EFCAB4A
|
EF-hand calcium binding domain 4A |
chr2_-_75426826 | 1.18 |
ENST00000305249.5
|
TACR1
|
tachykinin receptor 1 |
chr7_+_22766766 | 1.18 |
ENST00000426291.1
ENST00000401651.1 ENST00000258743.5 ENST00000420258.2 ENST00000407492.1 ENST00000401630.3 ENST00000406575.1 |
IL6
|
interleukin 6 (interferon, beta 2) |
chr16_-_88933014 | 1.18 |
ENST00000378358.4
ENST00000419291.2 ENST00000427766.1 ENST00000411789.2 ENST00000547152.1 |
PABPN1L
|
poly(A) binding protein, nuclear 1-like (cytoplasmic) |
chr17_-_72968837 | 1.18 |
ENST00000581676.1
|
HID1
|
HID1 domain containing |
chr19_+_5904866 | 1.17 |
ENST00000339485.3
|
VMAC
|
vimentin-type intermediate filament associated coiled-coil protein |
chr17_+_43299156 | 1.17 |
ENST00000331495.3
|
FMNL1
|
formin-like 1 |
chr22_-_24181174 | 1.17 |
ENST00000318109.7
ENST00000406855.3 ENST00000404056.1 ENST00000476077.1 |
DERL3
|
derlin 3 |
chr2_-_175869936 | 1.15 |
ENST00000409900.3
|
CHN1
|
chimerin 1 |
chrX_+_13587712 | 1.12 |
ENST00000361306.1
ENST00000380602.3 |
EGFL6
|
EGF-like-domain, multiple 6 |
chr13_+_112721913 | 1.12 |
ENST00000330949.1
|
SOX1
|
SRY (sex determining region Y)-box 1 |
chr14_+_62584197 | 1.12 |
ENST00000334389.4
|
LINC00643
|
long intergenic non-protein coding RNA 643 |
chr19_-_7764960 | 1.11 |
ENST00000593418.1
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23) |
chr19_+_55795493 | 1.11 |
ENST00000309383.1
|
BRSK1
|
BR serine/threonine kinase 1 |
chr4_+_40198527 | 1.10 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr5_+_34656569 | 1.10 |
ENST00000428746.2
|
RAI14
|
retinoic acid induced 14 |
chr14_-_106471723 | 1.09 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr1_-_202129704 | 1.09 |
ENST00000476061.1
ENST00000544762.1 ENST00000467283.1 ENST00000464870.1 ENST00000435759.2 ENST00000486116.1 ENST00000543735.1 ENST00000308986.5 ENST00000477625.1 |
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr12_+_27485823 | 1.09 |
ENST00000395901.2
ENST00000546179.1 |
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
chr7_+_142008340 | 1.09 |
ENST00000390387.3
|
TRBV3-1
|
T cell receptor beta variable 3-1 |
chr2_+_173600565 | 1.09 |
ENST00000397081.3
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr16_+_33629600 | 1.09 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
chr4_-_6202291 | 1.08 |
ENST00000282924.5
|
JAKMIP1
|
janus kinase and microtubule interacting protein 1 |
chr17_-_3867585 | 1.08 |
ENST00000359983.3
ENST00000352011.3 ENST00000397043.3 ENST00000397041.3 ENST00000397035.3 ENST00000397039.1 ENST00000309890.7 |
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous |
chr1_+_203444887 | 1.07 |
ENST00000343110.2
|
PRELP
|
proline/arginine-rich end leucine-rich repeat protein |
chr6_-_132722604 | 1.06 |
ENST00000392401.3
ENST00000367963.3 |
MOXD1
|
monooxygenase, DBH-like 1 |
chr7_+_142012967 | 1.06 |
ENST00000390357.3
|
TRBV4-1
|
T cell receptor beta variable 4-1 |
chr15_-_95870348 | 1.06 |
ENST00000556899.1
|
CTD-2536I1.1
|
CTD-2536I1.1 |
chr4_-_6202247 | 1.06 |
ENST00000409021.3
ENST00000409371.3 |
JAKMIP1
|
janus kinase and microtubule interacting protein 1 |
chr1_+_95285896 | 1.06 |
ENST00000446120.2
ENST00000271227.6 ENST00000527077.1 ENST00000529450.1 |
SLC44A3
|
solute carrier family 44, member 3 |
chr11_+_131781290 | 1.04 |
ENST00000425719.2
ENST00000374784.1 |
NTM
|
neurotrimin |
chr19_-_52227221 | 1.04 |
ENST00000222115.1
ENST00000540069.2 |
HAS1
|
hyaluronan synthase 1 |
chr1_+_95286151 | 1.03 |
ENST00000467909.1
ENST00000422520.2 ENST00000532427.1 |
SLC44A3
|
solute carrier family 44, member 3 |
chr17_+_7239904 | 1.03 |
ENST00000575425.1
|
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr5_+_34656529 | 1.03 |
ENST00000513974.1
ENST00000512629.1 |
RAI14
|
retinoic acid induced 14 |
chr16_+_23847267 | 1.02 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chrX_-_151143140 | 1.02 |
ENST00000393914.3
ENST00000370328.3 ENST00000370325.1 |
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon |
chr19_+_7660716 | 1.02 |
ENST00000160298.4
ENST00000446248.2 |
CAMSAP3
|
calmodulin regulated spectrin-associated protein family, member 3 |
chr16_+_29150963 | 1.01 |
ENST00000563477.1
|
RP11-426C22.5
|
RP11-426C22.5 |
chr11_+_44748361 | 1.01 |
ENST00000533202.1
ENST00000533080.1 ENST00000520358.2 ENST00000520999.2 |
TSPAN18
|
tetraspanin 18 |
chr17_+_77021702 | 1.01 |
ENST00000392445.2
ENST00000354124.3 |
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr5_-_94620239 | 1.01 |
ENST00000515393.1
|
MCTP1
|
multiple C2 domains, transmembrane 1 |
chr17_+_7239821 | 1.00 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr2_-_232791038 | 1.00 |
ENST00000295440.2
ENST00000409852.1 |
NPPC
|
natriuretic peptide C |
chr3_+_2140476 | 1.00 |
ENST00000422330.1
|
CNTN4
|
contactin 4 |
chr2_-_190044480 | 1.00 |
ENST00000374866.3
|
COL5A2
|
collagen, type V, alpha 2 |
chr19_+_16187085 | 1.00 |
ENST00000300933.4
|
TPM4
|
tropomyosin 4 |
chr18_+_905104 | 0.99 |
ENST00000579794.1
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary) |
chr20_+_56725952 | 0.99 |
ENST00000371168.3
|
C20orf85
|
chromosome 20 open reading frame 85 |
chr12_+_27849378 | 0.98 |
ENST00000310791.2
|
REP15
|
RAB15 effector protein |
chr7_+_50344289 | 0.98 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr6_-_32077100 | 0.98 |
ENST00000375244.3
ENST00000375247.2 |
TNXB
|
tenascin XB |
chr16_+_88704978 | 0.97 |
ENST00000244241.4
|
IL17C
|
interleukin 17C |
chr17_-_8534031 | 0.97 |
ENST00000411957.1
ENST00000396239.1 ENST00000379980.4 |
MYH10
|
myosin, heavy chain 10, non-muscle |
chr17_-_8534067 | 0.97 |
ENST00000360416.3
ENST00000269243.4 |
MYH10
|
myosin, heavy chain 10, non-muscle |
chr21_-_39870339 | 0.97 |
ENST00000429727.2
ENST00000398905.1 ENST00000398907.1 ENST00000453032.2 ENST00000288319.7 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr7_+_70597109 | 0.97 |
ENST00000333538.5
|
WBSCR17
|
Williams-Beuren syndrome chromosome region 17 |
chr16_+_330581 | 0.96 |
ENST00000219409.3
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr12_+_27485785 | 0.95 |
ENST00000544915.1
|
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
chr12_-_77272765 | 0.95 |
ENST00000547435.1
ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2
|
cysteine and glycine-rich protein 2 |
chr8_+_98881268 | 0.95 |
ENST00000254898.5
ENST00000524308.1 ENST00000522025.2 |
MATN2
|
matrilin 2 |
chr19_+_46806856 | 0.94 |
ENST00000300862.3
|
HIF3A
|
hypoxia inducible factor 3, alpha subunit |
chr18_-_71959159 | 0.93 |
ENST00000494131.2
ENST00000397914.4 ENST00000340533.4 |
CYB5A
|
cytochrome b5 type A (microsomal) |
chr1_-_27339317 | 0.93 |
ENST00000289166.5
|
FAM46B
|
family with sequence similarity 46, member B |
chr4_+_184826418 | 0.93 |
ENST00000308497.4
ENST00000438269.1 |
STOX2
|
storkhead box 2 |
chr16_+_66400533 | 0.93 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr12_-_49259643 | 0.93 |
ENST00000309739.5
|
RND1
|
Rho family GTPase 1 |
chr7_-_22396533 | 0.93 |
ENST00000344041.6
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
chr15_-_95870310 | 0.93 |
ENST00000508732.2
|
CTD-2536I1.1
|
CTD-2536I1.1 |
chr4_-_2420335 | 0.92 |
ENST00000503000.1
|
ZFYVE28
|
zinc finger, FYVE domain containing 28 |
chr17_+_34538310 | 0.92 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
chr2_-_20425158 | 0.92 |
ENST00000381150.1
|
SDC1
|
syndecan 1 |
chr3_+_19189946 | 0.92 |
ENST00000328405.2
|
KCNH8
|
potassium voltage-gated channel, subfamily H (eag-related), member 8 |
chr5_-_145214893 | 0.91 |
ENST00000394450.2
|
PRELID2
|
PRELI domain containing 2 |
chr6_-_31697255 | 0.91 |
ENST00000436437.1
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2 |
chr16_+_22524379 | 0.91 |
ENST00000536620.1
|
NPIPB5
|
nuclear pore complex interacting protein family, member B5 |
chr5_+_113697983 | 0.91 |
ENST00000264773.3
|
KCNN2
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
chr1_-_37499726 | 0.90 |
ENST00000373091.3
ENST00000373093.4 |
GRIK3
|
glutamate receptor, ionotropic, kainate 3 |
chr9_+_6758024 | 0.90 |
ENST00000442236.2
|
KDM4C
|
lysine (K)-specific demethylase 4C |
chr20_-_4982132 | 0.90 |
ENST00000338244.1
ENST00000424750.2 |
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2 |
chr10_+_112836779 | 0.90 |
ENST00000280155.2
|
ADRA2A
|
adrenoceptor alpha 2A |
chr2_-_87017985 | 0.90 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
chr12_+_56325812 | 0.90 |
ENST00000394147.1
ENST00000551156.1 ENST00000553783.1 ENST00000557080.1 ENST00000432422.3 ENST00000556001.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr19_+_49838653 | 0.89 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr12_+_27485889 | 0.89 |
ENST00000311001.5
ENST00000261178.5 ENST00000266503.5 |
ARNTL2
|
aryl hydrocarbon receptor nuclear translocator-like 2 |
chr1_-_202129105 | 0.89 |
ENST00000367279.4
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr3_-_65583561 | 0.89 |
ENST00000460329.2
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
chr10_+_18429671 | 0.88 |
ENST00000282343.8
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr15_+_63889552 | 0.88 |
ENST00000360587.2
|
FBXL22
|
F-box and leucine-rich repeat protein 22 |
chr10_+_73156664 | 0.87 |
ENST00000398809.4
ENST00000398842.3 ENST00000461841.3 ENST00000299366.7 |
CDH23
|
cadherin-related 23 |
chr9_+_6757634 | 0.87 |
ENST00000543771.1
ENST00000401787.3 ENST00000381306.3 ENST00000381309.3 |
KDM4C
|
lysine (K)-specific demethylase 4C |
chr16_+_68678739 | 0.87 |
ENST00000264012.4
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr17_+_34431212 | 0.87 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr12_-_80084333 | 0.87 |
ENST00000552637.1
|
PAWR
|
PRKC, apoptosis, WT1, regulator |
chr8_+_56014949 | 0.87 |
ENST00000327381.6
|
XKR4
|
XK, Kell blood group complex subunit-related family, member 4 |
chr2_-_157189180 | 0.86 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
chr15_+_63889577 | 0.86 |
ENST00000534939.1
ENST00000539570.3 |
FBXL22
|
F-box and leucine-rich repeat protein 22 |
chr19_-_39805976 | 0.86 |
ENST00000248668.4
|
LRFN1
|
leucine rich repeat and fibronectin type III domain containing 1 |
chr7_+_116165754 | 0.86 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr9_-_117880477 | 0.86 |
ENST00000534839.1
ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC
|
tenascin C |
chr11_-_18813353 | 0.86 |
ENST00000358540.2
ENST00000396171.4 ENST00000396167.2 |
PTPN5
|
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
chr19_-_51220176 | 0.86 |
ENST00000359082.3
ENST00000293441.1 |
SHANK1
|
SH3 and multiple ankyrin repeat domains 1 |
chr8_+_103876528 | 0.86 |
ENST00000522939.1
ENST00000524007.1 |
KB-1507C5.2
|
HCG15011, isoform CRA_a; Protein LOC100996457 |
chr17_-_26695013 | 0.85 |
ENST00000555059.2
|
CTB-96E2.2
|
Homeobox protein SEBOX |
chr4_-_25865159 | 0.85 |
ENST00000502949.1
ENST00000264868.5 ENST00000513691.1 ENST00000514872.1 |
SEL1L3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr17_+_43299241 | 0.84 |
ENST00000328118.3
|
FMNL1
|
formin-like 1 |
chr8_+_126010783 | 0.84 |
ENST00000521232.1
|
SQLE
|
squalene epoxidase |
chr16_+_68679193 | 0.84 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr7_-_123673471 | 0.84 |
ENST00000455783.1
|
TMEM229A
|
transmembrane protein 229A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 3.2 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
1.0 | 6.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.8 | 3.3 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.8 | 3.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 0.6 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.6 | 2.5 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.6 | 1.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
0.5 | 1.5 | GO:0048627 | myoblast development(GO:0048627) |
0.5 | 2.3 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.5 | 1.4 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.4 | 3.3 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 1.2 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.4 | 1.1 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
0.4 | 0.7 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.3 | 0.3 | GO:0003292 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.3 | 1.0 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 2.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.3 | 1.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.3 | 54.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.3 | 0.9 | GO:0001890 | placenta development(GO:0001890) |
0.3 | 2.2 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.3 | 1.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 2.4 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.3 | 0.9 | GO:0015993 | L-ascorbic acid transport(GO:0015882) molecular hydrogen transport(GO:0015993) transepithelial L-ascorbic acid transport(GO:0070904) |
0.3 | 2.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.3 | 1.1 | GO:0060032 | notochord regression(GO:0060032) |
0.3 | 0.9 | GO:0050894 | determination of affect(GO:0050894) |
0.3 | 2.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.3 | 1.1 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 1.4 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.3 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 2.2 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.3 | 0.8 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.3 | 1.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 1.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 0.8 | GO:0060596 | mammary placode formation(GO:0060596) |
0.3 | 1.0 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.2 | 0.7 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 1.2 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 0.7 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.2 | 0.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.2 | 0.7 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.2 | 1.4 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 1.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.9 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.7 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.2 | 0.7 | GO:1900369 | transcription, RNA-templated(GO:0001172) negative regulation of RNA interference(GO:1900369) |
0.2 | 2.4 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.2 | 0.6 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.2 | 0.6 | GO:0040040 | thermosensory behavior(GO:0040040) |
0.2 | 1.9 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.2 | 1.0 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 1.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 0.8 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.2 | 1.0 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.2 | 1.7 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 2.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 1.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.5 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.2 | 0.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 0.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.2 | 0.5 | GO:0070295 | renal water absorption(GO:0070295) |
0.2 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.2 | 0.5 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.8 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
0.2 | 0.5 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
0.1 | 0.4 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
0.1 | 0.4 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 1.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.6 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.9 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 1.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 1.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.7 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.1 | 1.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.4 | GO:2000974 | auditory receptor cell fate determination(GO:0042668) negative regulation of pro-B cell differentiation(GO:2000974) |
0.1 | 0.4 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.1 | 0.7 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.1 | 0.5 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 0.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.5 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.4 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 0.9 | GO:2000503 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 1.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.4 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 1.4 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.1 | 1.4 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.5 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 1.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.1 | 2.0 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.5 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 1.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.7 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.1 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.1 | 0.4 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.1 | 0.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.3 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
0.1 | 1.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.1 | 0.4 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.1 | 0.6 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 1.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.3 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.3 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.1 | 0.8 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.1 | 1.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 2.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.8 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.3 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 1.6 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.9 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 1.4 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.6 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.1 | 0.6 | GO:0071964 | regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
0.1 | 0.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.8 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.3 | GO:0032827 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 1.0 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.4 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 3.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.8 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 1.0 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.1 | 1.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 3.1 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 1.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 1.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.5 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.7 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.3 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 1.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.1 | 0.4 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.8 | GO:1900024 | regulation of substrate adhesion-dependent cell spreading(GO:1900024) negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.2 | GO:1902993 | positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.1 | 0.2 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.1 | 1.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.9 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.1 | 2.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 1.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.6 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 0.4 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
0.1 | 1.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.9 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 2.7 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.1 | 0.6 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.2 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.3 | GO:0030500 | regulation of bone mineralization(GO:0030500) regulation of biomineral tissue development(GO:0070167) |
0.1 | 0.1 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.6 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.1 | 0.8 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 8.5 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 1.7 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.1 | 0.7 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.1 | 0.4 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.3 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.5 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.1 | 0.2 | GO:0060319 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) primitive erythrocyte differentiation(GO:0060319) |
0.1 | 0.3 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 1.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) negative regulation of metallopeptidase activity(GO:1905049) |
0.1 | 1.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.3 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.2 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.1 | 0.2 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) |
0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.5 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.4 | GO:0060318 | regulation of definitive erythrocyte differentiation(GO:0010724) definitive erythrocyte differentiation(GO:0060318) |
0.1 | 0.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.3 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 0.6 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.7 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.0 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.8 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.0 | 0.1 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) |
0.0 | 0.9 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.0 | 0.8 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.4 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.0 | 0.2 | GO:0046833 | snRNA export from nucleus(GO:0006408) positive regulation of RNA export from nucleus(GO:0046833) |
0.0 | 0.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 0.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 1.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.0 | 0.2 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
0.0 | 2.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.3 | GO:0018212 | peptidyl-tyrosine phosphorylation(GO:0018108) peptidyl-tyrosine modification(GO:0018212) |
0.0 | 0.2 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.0 | 0.2 | GO:0010975 | regulation of neuron projection development(GO:0010975) |
0.0 | 0.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.0 | 0.2 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.0 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0010193 | response to ozone(GO:0010193) |
0.0 | 0.6 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.5 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 1.1 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.8 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.0 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 1.0 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.3 | GO:1902991 | regulation of amyloid precursor protein catabolic process(GO:1902991) |
0.0 | 0.1 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.0 | 0.7 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.0 | 0.4 | GO:1902866 | negative regulation of excitatory postsynaptic potential(GO:0090394) regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.7 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.2 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.0 | 14.5 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.5 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 2.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.7 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.4 | GO:0006833 | water transport(GO:0006833) fluid transport(GO:0042044) |
0.0 | 0.1 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.0 | 1.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 1.8 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.0 | 1.7 | GO:0045576 | mast cell activation(GO:0045576) |
0.0 | 0.4 | GO:0030238 | male sex determination(GO:0030238) |
0.0 | 0.1 | GO:0001079 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.0 | 0.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.9 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.3 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 1.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 1.5 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 1.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.0 | 0.5 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.6 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:0070940 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.9 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.1 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
0.0 | 0.3 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.0 | 0.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 1.7 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.0 | 0.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.0 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.3 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.0 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.0 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.1 | GO:0015862 | uridine transport(GO:0015862) |
0.0 | 0.6 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.0 | 2.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.6 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 1.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.6 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.0 | 0.3 | GO:0008284 | positive regulation of cell proliferation(GO:0008284) |
0.0 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.3 | GO:0015669 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.0 | 0.3 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.5 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.2 | GO:0001503 | ossification(GO:0001503) |
0.0 | 1.0 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 1.1 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.0 | 0.5 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.4 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.0 | 0.1 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.1 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.0 | 0.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.6 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.0 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.0 | 0.0 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.0 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.0 | 0.8 | GO:1903169 | regulation of calcium ion transmembrane transport(GO:1903169) |
0.0 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.0 | GO:0006272 | leading strand elongation(GO:0006272) |
0.0 | 0.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.0 | 0.6 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.0 | 0.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.2 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.6 | 3.2 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.5 | 2.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 25.0 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.4 | 1.2 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.4 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.2 | 1.4 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 1.7 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 2.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 0.7 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.2 | 2.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 5.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 0.8 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 2.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 1.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 2.5 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.5 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.2 | 0.5 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 0.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.7 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.1 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.4 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.6 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.1 | 2.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 1.1 | GO:0031095 | platelet dense tubular network(GO:0031094) platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.7 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.1 | 2.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 1.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 1.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 2.0 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 0.8 | GO:0042025 | host cell nucleus(GO:0042025) |
0.1 | 0.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.6 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 3.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 2.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 6.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 1.2 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 1.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.3 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 0.3 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 1.4 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 1.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 2.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.1 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 1.6 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 1.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.0 | 0.4 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 7.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 1.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.0 | 1.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.3 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 1.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.4 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 1.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.0 | 0.2 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 1.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 3.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 3.2 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 5.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.5 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.3 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 2.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 1.1 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 7.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.8 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 1.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.1 | GO:0000235 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.0 | 1.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 5.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.6 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.6 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.6 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0032044 | DSIF complex(GO:0032044) |
0.0 | 0.8 | GO:0098794 | postsynapse(GO:0098794) |
0.0 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.0 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.0 | 0.4 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 2.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.0 | 1.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.6 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.0 | 2.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 1.6 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 2.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 1.2 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.9 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.8 | 3.3 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.5 | 2.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.5 | 4.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.5 | 1.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 1.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 1.5 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.4 | 0.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 24.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.3 | 1.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.3 | 0.7 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 0.9 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 0.9 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 0.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.3 | 0.9 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.3 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 1.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 1.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 2.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.2 | 1.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.2 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 1.1 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.2 | 0.6 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.2 | 1.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.2 | 46.6 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 0.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.2 | 0.8 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.2 | 0.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 2.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.2 | 0.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 0.5 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 0.8 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.2 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 1.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 2.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.4 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 1.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.1 | 1.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 1.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 1.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.5 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 0.8 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 0.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 1.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 3.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.3 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 1.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.3 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
0.1 | 1.1 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.3 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.1 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 2.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 2.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 2.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 2.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 3.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.5 | GO:0033906 | protein tyrosine kinase inhibitor activity(GO:0030292) hyaluronoglucuronidase activity(GO:0033906) |
0.1 | 2.8 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.7 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.1 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 1.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.4 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 1.9 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.6 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.6 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0048763 | HLH domain binding(GO:0043398) calcium-induced calcium release activity(GO:0048763) |
0.1 | 1.2 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 3.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 2.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 3.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.6 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 0.6 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 1.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.1 | 0.3 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 1.3 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 2.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.8 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 1.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 1.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 2.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 1.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.0 | 0.4 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 1.6 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 1.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 1.1 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.4 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.0 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 2.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 1.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.0 | 0.1 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.0 | 1.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.6 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.0 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.9 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 1.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 4.1 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.1 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.0 | 1.0 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 1.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.5 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.6 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.3 | GO:0008865 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.5 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 0.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 2.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.5 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.6 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.0 | 1.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.0 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 1.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 2.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 2.8 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.4 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.7 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 1.1 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0047708 | biotinidase activity(GO:0047708) |
0.0 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.0 | 0.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.8 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.0 | 0.1 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.2 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.5 | GO:0004407 | histone deacetylase activity(GO:0004407) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 4.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 4.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 3.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 1.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 4.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 3.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 2.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 3.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 3.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 2.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 3.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 4.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 8.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 1.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 2.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 2.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 5.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.7 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 3.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 3.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 4.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 0.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 1.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 4.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.8 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 3.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.1 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 1.7 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 2.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 4.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 9.2 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 4.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 4.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 1.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 2.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.7 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 1.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 2.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 1.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 2.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.3 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 1.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.5 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 1.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 1.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.2 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 1.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |